A group of national medical associations and doctors urged a federal court on Feb. 10 to order a federal regulator to reverse its two-decade-old approval of Mifepristone, a drug used for medication abortions that critics say endangers women who use it.
The abortion pill has become a focus of legal efforts by the pro-life movement since the Supreme Court overturned the 49-year-old Roe v. Wade precedent in June 2022, returning the regulation of abortion to the states, several of which have since banned or restricted abortions.